OTC Picks

[Robertscott]

$PVSP Pervasip currently has about 5,000,000,000 shares of common stock issued and outstanding, corresponding to about 15% of Pervasip’s fully diluted issued and outstanding common stock. Pervasip additionally has 850,000 shares of Series K convertible preferred stock issued and outstanding, corresponding to 85% of Pervasip’s fully diluted issued and outstanding common stock, as well as various other convertible securities.

[Let's Roll]

$PVSP Pervasip currently has about 5,000,000,000 shares of common stock issued and outstanding, corresponding to about 15% of Pervasip’s fully diluted issued and outstanding common stock. Pervasip additionally has 850,000 shares of Series K convertible preferred stock issued and outstanding, corresponding to 85% of Pervasip’s fully diluted issued and outstanding common stock, as well as various other convertible securities.

https://www.morningstar.com/news/globe-newswire/8730826/pervasip-announces-artizen-spin-off

[Robertscott]

$PVSP Holding 16% gain

[Robertscott]

$PVSP While the local Washington market presents compelling opportunities for the acquisition and roll-up of wholesale flower, concentrate, and other related production assets by Zen’s independent cultivators, the regulatory environment in Washington prevents vertical integration into retail assets. That limitation is a significant constraint on growth since Zen’s independent cultivators cannot acquire dispensary assets to internalize retail revenues that are typically about three times wholesale receipts. Stated differently, Artizen could be generating about three times its current revenues, or about $46 to $52 million, if Zen’s existing footprint was in another state. Thus, diversification has been and remains a key strategic focus – both within Washington by expanding Zen’s offerings and exploiting compliant acquisition opportunities, and in valuable emerging cannabis markets by replicating Artizen’s proven formula for success in new U.S. and Canadian geographies.

https://www.barrons.com/articles/pervasip-announces-artizen-spin-off-01673965206?mod=md_stockoverview_news

[Let's Roll]

$PVSP Artizen Corp will have a cleaner, more easily fund able capital structure.

[Let's Roll]

$PVSP While nobody knows, if you do basic math from all of the publicly available data, current enterprise value of Pervasip (=all Artizen) comes in at around $40 million on a fully diluted basis without any forward-looking value attached;

That is CURRENT value; when the company announces its various licensing and acquisition opportunities, the stock will only go up from there!

[Let's Roll]

$PVSP You must be a Pervasip shareholder of record at the Record Date to take advantage of this double; buying a PVSP share the day after will not transfer to Artizen Corp

[Robertscott]

$PVSP Jan. 17, 2023 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTCPK: PVSP) (“Pervasip” and the “Company”) today announced that it will spin-off 100% of its wholly-owned subsidiary, Artizen Corporation (“Artizen”), as a separate public company, with an anticipated record date between July 1, 2023, and September 30, 2023. As a result of the spin-off, all Pervasip shareholders of record as of the designated record date shall receive shares in the newly public Artizen in proportion to their ownership in Pervasip. Artizen conducts 100% of Pervasip’s cannabis business segment operations through its Zen Asset Management LLC subsidiary ("Zen”).

Positioning for Expansion

“Spinning out Artizen will allow us to properly capitalize the business to take advantage of multiple expansion opportunities to build on our existing foundation,” said German Burtscher, Chairman and Chief Executive Officer of Pervasip and Artizen.

Pervasip previously announced its identification of a series of exciting expansion opportunities, including potential acquisitions involving licensed wholesale and retail operations that would offer Artizen the potential to establish itself as a vertically integrated multi-state operator (“MSO”).

While the local Washington market presents compelling opportunities for the acquisition and roll-up of wholesale flower, concentrate, and other related production assets by Zen’s independent cultivators, the regulatory environment in Washington prevents vertical integration into retail assets. That limitation is a significant constraint on growth since Zen’s independent cultivators cannot acquire dispensary assets to internalize retail revenues that are typically about three times wholesale receipts. Stated differently, Artizen could be generating about three times its current revenues, or about $46 to $52 million, if Zen’s existing footprint was in another state. Thus, diversification has been and remains a key strategic focus – both within Washington by expanding Zen’s offerings and exploiting compliant acquisition opportunities, and in valuable emerging cannabis markets by replicating Artizen’s proven formula for success in new U.S. and Canadian geographies.

Burtscher added, “Timing is important. The valuations and fates of MSOs and other participants in the cannabis industry have vacillated in several waves since state legalization commenced. We believe that increased legalization is inevitable in time, both at the federal level and in the form of improved regulatory environments in Washington. Preparing ourselves for that day is an important aspect of our long-term plans, including by expanding our brands and building on our footprint in valuable new geographies, and accessing long term equity capital to do so with shareholder friendly structures. Critically, the Artizen capital structure after the spin-out is completed has been specifically designed to allow us to raise equity financing on terms that vastly exceed anything that we can accomplish with Pervasip’s current capital structure.”

[Robertscott]

$PVSP Intereactive Chart https://www.barchart.com/stocks/quotes/PVSP/interactive-chart

[Let's Roll]

$PVSP Pervasip Corp., a developer of companies and technologies in high value emerging markets, owns Artizen Corporation and its subsidiary, Zen Asset Management LLC, a diversified asset management company founded to acquire, develop, and support companies and technologies in the cannabis industry. ZAM’s existing clients operate four licensed cannabis cultivation and one processing facility in Washington. Most of the biomass produced by these independent cultivators has been sold historically under the Artizen™ brand, including all-time top selling products in flower in Washington state. Additional information on Artizen-branded products is available online at www.artizencannabis.com. Pervasip additionally owns 5% of KRTL Biotech, Inc., a developer of biotechnologies with a focus on pharmaceutical applications of cannabinol and psilocybin. Additional information on KRTL is available online at www.krtlbiotech.com.

[Robertscott]

$PVSP Intereactive Chart https://www.barchart.com/stocks/quotes/PVSP/interactive-chart

[tsongbird]

$BIEL sells in all these countries!

Countries now selling $BIEL products ActiPatch® /RecoveryRx® /KT Recovery+ Wave™/ Smart Insole™/ HealFast® Pet Patch Loop

USA https://www.bielcorp.com/ https://www.recoveryrx.co/ https://www.donjoyperformance.com https://www.kttape.com
Greece https://gmtpshop.com/shop/physicotherapeftika/siskeves-ilektrotherapias-tens/recovery-rx/
http://actipatch.elitehost.gr/%CF%80%CF%81%CE%BF%CF%8A%CF%8C%CE%BD/allay-%CE%B3%CE%B9%CE%B1-%CF%84%CE%BF%CF%85%CF%82-%CF%80%CF%8C%CE%BD%CE%BF%CF%85%CF%82-%CF%84%CE%B7%CF%82-%CF%80%CE%B5%CF%81%CE%B9%CF%8C%CE%B4%CE%BF%CF%85/
Spain https://www.prim.es/ https://www.docmorris.pt/pt/actipatch-alivio-para-el-dolor-de-espalda-baja/p-129328
Corsica https://www.docmorris.pt/pt/actipatch-kit-dolori-schiena-pharmatech-srl/p-306738
https://www.docmorris.pt/pt/actipatch-kit-dolori-schiena-pharmatech-srl/p-306738
Mexico https://globaltech.com.mx/
Saudi Arabia https://www.stada.com/
Bahrain https://www.stada.com/
Lebanon https://www.clinovations.com/
Qatar http://www.mdmedical.co/recoveryrx.html
Oman http://www.mdmedical.co/recoveryrx.html
United Arab Emirates http://www.mdmedical.co/recoveryrx.html
Kuwait http://www.mdmedical.co/recoveryrx.html
Slovenia https://protibolecinska-zanka.com/?fbclid=IwAR2pWP6ikD-vxB6XB5mGfH47CwWEuABcPbBaT0xb5YN9xGxz504xVuOKlCk
Poland https://www.ubuy.com.pl/en/product/2DQGJO8-kt-tape-kt-recovery-wave-electromagnetic-pain-relief-device
Romania https://www.directpharma.ro/
Estonia https://msa.sm.ee/ctrl/en/MeditsiiniSeade/andmed/17178 https://monger.eu/kttape/en/toode/kt-recovery-wave/
Lithuania https://www.ubuy.lt/en/product/MPTPWE-actipatch-knee-pain-advanced-long-lasting-relief-packaging-may-varry
Japan https://www.u-buy.jp/en/product/2DQGJO8-kt-tape-kt-recovery-wave-electromagnetic-pain-relief-device
United Kingdom https://www.kttape.co.uk/products/kt-recovery-wave-%E2%84%A2
https://www.healthstuff.co.uk/en/us/ActiPatch-Knee-Pain-Reviews/r-3215.aspx
https://www.chemist-4-u.com/catalogsearch/result/?q=actipatch
France https://www.docmorris.pt/pt/avafarma-dolor-7-dias/p-137623
Ireland https://www.inishpharmacy.com/p/actipatch-electromagnetic-pulse-therapy-back-pain/actipatch-back
Germany https://www.amazon.de/-/en/ActiPatch-Knee-Joint-Pain-Kit/dp/B00RLLMVNK
Austria http://www.actipatch.at/
Australia https://actipatch.com.au/
Canada https://airwaysurgical.ca/
New Zealand https://thebalancedpet.co.za/shop/healfast-therapy-petpatch-loop/
Italy https://oneglobebio.com/
Finland https://kir-fix.fi/kauppa/actipatch-laakinnallinen-laite-kroonisen-kivun-hoitoon/
Sweden https://www.actipatch.se/
Korea https://www.huons.com/eng/home.php?go=main
South Africa https://www.adcock.co.za/
Bangladesh https://www.facebook.com/mhplbd/
Taiwan http://www.abmt.com.tw/
China https://cicdtech.en.made-in-china.com/product/TZiasMQvCpYj/China-Drug-Free-Pain-Relief-Electromagnetic-Pulse-Medical-Physical-Therapy-Equipment.html

https://www.facebook.com/profile.php?id=100076211491337









]

[tsongbird]

$BIEL Partnered with Modern Development Medical Co.

Modern Development Medical Co.
MD is the fastests growing medical company in Kuwait
Now distributing Recovery Rx® and ActiPatch® to medical professionals
http://mdmedical.co/bio-electronics.html

[Let's Roll]

$PVSP You must be a Pervasip shareholder of record at the Record Date to take advantage of this double; buying a PVSP share the day after will not transfer to Artizen Corp

[Robertscott]

$PVSP Positioning for Expansion

“Spinning out Artizen will allow us to properly capitalize the business to take advantage of multiple expansion opportunities to build on our existing foundation,” said German Burtscher, Chairman and Chief Executive Officer of Pervasip and Artizen.

[Let's Roll]

$PVSP Pervasip currently has about 5,000,000,000 shares of common stock issued and outstanding, corresponding to about 15% of Pervasip’s fully diluted issued and outstanding common stock. Pervasip additionally has 850,000 shares of Series K convertible preferred stock issued and outstanding, corresponding to 85% of Pervasip’s fully diluted issued and outstanding common stock, as well as various other convertible securities.

https://www.morningstar.com/news/globe-newswire/8730826/pervasip-announces-artizen-spin-off

[Let's Roll]

$PVSP Artizen Corp will have a cleaner, more easily fund able capital structure.

[Robertscott]

$PVSP Artizen On Instagram:

https://www.instagram.com/reel/CVRjKSOBw4c/

[AyaStocks]

$AGYP signs MOU with Enerhash (crypto mining industry leader) to begin Flare Gas Bitcoin Mining project!

https://www.otcmarkets.com/stock/AGYP/news/Allied-Energy-Signs-MOU-with-Enerhash-USA-to-Begin-Initial-Flare-Gas-Bitcoin-Mining-Data-Center-Project?id=382189

[FinlayS00]

$LUDG - Ludwig Enterprises, Inc. has announced the acquisition of a nutraceutical formula from Xikoz, Inc. with a planned product release through MyRNA for Life, Inc. in Q1 of 2023. The has acquired an in-perpetuity license from Xikoz, Inc, of Sheridan, WY, for a dietary supplement formula. MyRNA will develop and market this nutraceutical formula, MyRNA for Life™. The compounds within this formula have the potential to modulate inflammatory conditions that are the root causes of many chronic diseases, including but not limited to cancer, heart disease, and diabetes.

https://finance.yahoo.com/news/ludwig-enterprises-acquires-cutting-edge-120000551.html

[Robertscott]

$MASN Maison Luxe Continues to Execute Its Growth Plan by Launching Luxury Sneaker E-Commerce Website: Kicks on Demand https://newmediawire.com/news/maison-luxe-continues-to-execute-its-growth-plan-by-launching-luxury-sneaker-e-commerce-website-kicks-on-demand-6848394

[ProfessorM]

$MASN PR from Tuesday! Maison Luxe Announces Additional $250,000 Purchase Order from Signet International Group for Upcoming Holiday Season
https://www.globenewswire.com/news-release/2022/12/06/2568258/0/en/Maison-Luxe-Announces-Additional-250-000-Purchase-Order-from-Signet-International-Group-for-Upcoming-Holiday-Season.html

[Let's Roll]

$PVSP ZAM provides consulting, leasing, intellectual property licensing and other long-term arrangements to cannabis operators, including management of the Artizen™ brand assets

https://www.pervasip.net/zen-asset-management-zam

[Let's Roll]

$PVSP ZAM provides consulting, leasing, intellectual property licensing and other long-term arrangements to cannabis operators, including management of the Artizen™ brand assets

https://www.pervasip.net/zen-asset-management-zam

[Let's Roll]

$PVSP As one of Washington’s original cannabis brands, Artizen - branded products are the all-time fourth best-selling in Washington across all product categories, and the all-time third in flower. The commitment to quality and consistency behind Artizen™ has built a substantial following, fueling more than $69 million in wholesale sales to a distribution network with more than 200 retailers, corresponding to more than $200 million in retail value since inception in 2015. ZAM is looking to expand its service into Oregon and California through similar long-term arrangements with cannabis licensees operating in these states

[Let's Roll]

$PVSP ZAM provides consulting, leasing, intellectual property licensing and other long-term arrangements to cannabis operators, including management of the Artizen™ brand assets

https://www.pervasip.net/zen-asset-management-zam

[Let's Roll]

$PVSP “Q3 2022 shows material signs of improvement over Q2 2022 reflecting our ongoing operational focus. As stated before, we continue to pursue our strategic goals even during these difficult market conditions as evidenced by our recent agreements on terms for the acquisition of the Emerald City Cultivation and Dabco brands. Our operational and financial focus on rationalizing our business, shedding underperforming assets, and increasing production yields by our independent cultivators continues to proceed and have allowed us to continue with additional market share capture. Investing in Cannabis is not for the faint of heart and we believe we are building a solid foundation for years to come which takes time, patience, and relentless focus on fundamentals. In an industry that does not have access to traditional financing, our options are limited and expensive,” said German Burtscher, Pervasip’s CEO. “We slowed the rollout of our new concentrate brands which we licensed for Q3 deployment and instead focused on an outright acquisition as the opportunity became available. That resulted in not meeting the forecasted revenue from the new product lineup for Q3. We are also pursuing a conservative approach to working within the complicated tax environment our industry is confronted with. Ongoing work in support of the audit process and a recent court ruling that impacts the cannabis industry caused us to change our estimates for tax liability dating back to prior periods 2017 – 2020, which we booked in Q3.”

https://seekingalpha.com/pr/18980304-pervasip-announces-3rd-quarter-financials

[Let's Roll]

$PVSP As one of Washington’s original cannabis brands, Artizen - branded products are the all-time fourth best-selling in Washington across all product categories, and the all-time third in flower. The commitment to quality and consistency behind Artizen™ has built a substantial following, fueling more than $69 million in wholesale sales to a distribution network with more than 200 retailers, corresponding to more than $200 million in retail value since inception in 2015. ZAM is looking to expand its service into Oregon and California through similar long-term arrangements with cannabis licensees operating in these states

[FinlayS00]

$CLIS - ClickStream Corp. will launch its subsidiary, Nifter™ during the annual Art Basel Miami Expo. Art Basel is supported by over 290 galleries and attended by over 88,000 of the world's top art collectors, celebrities, athletes, and influencers. The perfect timing of Nifter™'s launch at Art Basel will allow Nifter to showcase NFTs of ultra-rare trading cards, signed memorabilia by NBA legends, and art by renowned artists to Nifter’s target audience of art collectors.

Nifter™ will benefit greatly from the direct physical access to the global art-collecting community converging on Miami, as well as, set the tone for Nifter as a trusted, top-tiered art collection platform in the art world.

https://www.businesswire.com/news/home/20221122005383/en/

[Robertscott]

"$PVSP As we are getting closer to Thanksgiving a quick update on things here at Artizen:
1. Name change is well on its way with some changes NYS required
2. New brands are being introduced this month and getting ready for the holiday season"
3. And we are working on opportunities in Nevada, Virginia, and a few other spots to hit hard in 2023!"

[Let's Roll]

$PVSP Pervasip Announces 3rd Quarter Financials

https://finance.yahoo.com/news/pervasip-announces-3rd-quarter-financials-130000191.html

[FinlayS00]

$LUDG - Ludwig Inc.'s recent patent filing for a new method of diagnosing and treating chronic inflammation is a major breakthrough because chronic inflammation is at the root of many of today's most prevalent chronic diseases, including cancer, heart disease, and even long Covid.

The company also plans to file an S1 with the SEC in order to uplist Ludwig Enterprises to the NASDAQ market. This is a major milestone for the company and will allow it to raise capital to fund its continued growth and expansion. The S1 is expected to be filed in the next few weeks, and the company is confident that it will be approved by the SEC.

https://www.accesswire.com/viewarticle.aspx?id=726278

[Robertscott]

$PVSP Located south of Olympia, the Tumwater garden encompasses 25,900 square feet of cultivation and nursery and is home to the famous Dutchberry strain

[Let's Roll]

$PVSP ZAM provides consulting, leasing, intellectual property licensing and other long-term arrangements to cannabis operators, including management of the Artizen™ brand assets

https://www.pervasip.net/zen-asset-management-zam

[Let's Roll]

$PVSP Q3 2022 versus Q2 2022

Q3 2022 operating results improved over Q2 2022, tracking with ongoing efforts to shift bulk sales to higher margin brands combined with relative COGs reductions, even when adjusted for inventory.

SG&A expenses are slightly reduced, reflecting more of the ongoing restructuring of the business.

https://www.benzinga.com/pressreleases/22/10/g29305458/pervasip-announces-3rd-quarter-financials

[Robertscott]

$PVSP Key Highlights

Instead of focusing on a rollout of licensed Dabs and Vape4Less brands, the Company pursued an outright acquisition of those brands plus others, achieving more beneficial long-term value but not yet realizing respective revenue gains as indicated earlier.

Q3 shows margin improvement over Q2 as higher margin brands and products are coming online, a trend that will continue into Q4 2022.

The Company continues to pursue additional operational, financial, and legal restructuring to further clean and strengthen its balance sheet.

While expensive, the Company will continue to seek capital from available equity or debt sources.

The cannabis market on the Westcoast continues to see a dramatic post-pandemic retraction, creating a challenging environment for all producers, processors, and retailers. With an almost 18% contraction in retail revenues, massive oversupply, sustained downward price pressure and increasing costs, the industry is still months away from a recovery, although the bottom for pricing seems to have been reached.

https://www.morningstar.com/news/globe-newswire/8666987/pervasip-announces-3rd-quarter-financials

[FinlayS00]

$CLIS - ClickStream Corp. announced that its Nifter NFT marketplace has launched an end-to-end production and distribution department designed to make it simple for artists to produce viral content and collect royalties for music and video-based NFTs.

With this launch, Nifter expands its revenue streams beyond the sale of NFTs and positions Nifter as a "one-stop-shop" for artists to produce quality content, record royalty splits with Nifter's Rebel Blockchain, as well as collect royalties for music distributed on Apple Music, Spotify, and other streaming platforms.

https://finance.yahoo.com/news/nifter-launches-production-arm-produce-122700873.html

[Let's Roll]

$PVSP As one of Washington’s original cannabis brands, Artizen - branded products are the all-time fourth best-selling in Washington across all product categories, and the all-time third in flower. The commitment to quality and consistency behind Artizen™ has built a substantial following, fueling more than $69 million in wholesale sales to a distribution network with more than 200 retailers, corresponding to more than $200 million in retail value since inception in 2015. ZAM is looking to expand its service into Oregon and California through similar long-term arrangements with cannabis licensees operating in these states

[BottomBounce]

Electric Trucks $IDEX

[Robertscott]

$PVSP The below Washington State (WA) sales by category chart provides information on how monthly sales of approximately $100 million in retail sales breaks down by product category. It might also be informative to understand that June ’22 sales over June ’19 sales (pre pandemic) show an almost 17% increase. While WA sales are slightly above other mature cannabis states (NV, CO, OR), similar increases can be seen in those markets. An exuberant pandemic triggered belief in continued rapid growth has led to over development of production infrastructure and resulted in material oversupply of bulk cannabis flower. The market is in the process of correcting and the Company estimates Q3 2023 being the end of the corrective period, resulting in strengthening prices.

https://www.benzinga.com/pressreleases/22/09/g28756512/24-month-roadmap-to-50-million-in-sales

[Let's Roll]

$PVSP ZAM provides consulting, leasing, intellectual property licensing and other long-term arrangements to cannabis operators, including management of the Artizen™ brand assets

https://www.pervasip.net/zen-asset-management-zam

[FinlayS00]

$MLRT - MetAlert, Inc. is a pioneer in smart, mobile, and wearable tracking and recovery location-based solutions, supported through a proprietary IoT enterprise monitoring platform and intellectual property portfolio. The company offers a global end-to-end solution that includes hardware software connectivity all designed for seamless integration into consumer products as well enterprise applications with two-way GPS technology which enables subscribers to track people or high-value assets anywhere on earth via the miniaturized low-power consumption components enabled by the latest RF NFC BLE tech allowing them to monitor exactly where their loved ones are at any given time. With its cutting-edge technology and strong industry partnerships, MetAlert is a great stock for investors who are looking for long-term growth potential.

https://pubcoinsight.com/the-seven-best-performing-stocks-to-own-for-the-long-term/

[Robertscott]

$GOGY Technically sound https://www.barchart.com/stocks/quotes/GOGY/cheat-sheet

[Robertscott]

$GOGY On Facebook  https://www.facebook.com/GoldenGrailTechBeverages

[Robertscott]

$GOGY The Global Beverages Market Expected To Reach $1.8 Trillion By 2028 https://www.marketwatch.com/press-release/global-beverages-market-expected-to-reach-18-trillion-by-2028-2022-11-03-81974817?reflink=mw_share_twitter

[Robertscott]

$NBIO - Nascent to get US patent linked to brain cancer drug pritumumab

$GILD $PFE $VRTX $MRNA $REGN $BIIB $ABBV